E2F5, an important member of the E2F family, is a potential oncogene in breast cancer [21], ovarian cancer [22], HCC [23], esophageal squamous cell carcinoma [24], prostate cancer [25], and colorectal cancer [26]. This evidence concerns the gene E2F5 and prostate carcinoma.